Price T Rowe Associates Inc Arrowhead Pharmaceuticals, Inc. Transaction History
Price T Rowe Associates Inc
- $836 Billion
- Q2 2024
A detailed history of Price T Rowe Associates Inc transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 73,898 shares of ARWR stock, worth $1.58 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
73,898
Previous 71,136
3.88%
Holding current value
$1.58 Million
Previous $2.04 Million
5.6%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ARWR
# of Institutions
291Shares Held
91.6MCall Options Held
1.33MPut Options Held
549K-
Black Rock Inc. New York, NY15.7MShares$335 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$261 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.89MShares$190 Million3.15% of portfolio
-
State Street Corp Boston, MA5.84MShares$125 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.14MShares$88.3 Million2.11% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.26B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...